DCM Shriram Performance
- Today's Low
- ₹1,022
- Today's High
- ₹1,094
- 52 Week Low
- ₹945
- 52 Week High
- ₹1,502
- Open Price₹1,079
- Previous Close₹1,079
- Volume66,430
- 50 DMA₹1,140.00
- 100 DMA₹1,147.81
- 200 DMA₹1,158.35
DCM Shriram Chart
Investment Returns
- Over 1 Month -11%
- Over 3 Month -0.05%
- Over 6 Month -14.75%
- Over 1 Year -3.59%
Smart Investing Starts Here Start SIP with DCM Shriram for Steady Growth!
DCM Shriram Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.9
- PEG Ratio
- 0.5
- Market Cap Cr
- 16,167
- P/B Ratio
- 2.2
- Average True Range
- 44.18
- EPS
- 55.94
- Dividend Yield
- 1
- MACD Signal
- -13.41
- RSI
- 29.77
- MFI
- 13.13
Latest Stock News Updates
Conference Call with DCM Shriram Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 2 weeks 1 day ago
Diversified company DCM Shriram announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: Reported at Rs 3,373.03 crore in Q4FY26, showing a decline of 15.74% QoQ (from Rs 4,003.27 crore in Q3FY26) and a growth of 11.72% YoY (from Rs 3,019.32 crore in Q4FY25). For the full year FY26, revenue stood at Rs 14,263.91 crore, an increase of 11.95% YoY from Rs 12,741.32 crore in FY25. Total Income: Reached Rs 3,419.59 crore in Q4FY26, reflecting a decrease of 15.19% QoQ (from Rs 4,031.99 crore in Q3FY26) and an increase of 12.46% YoY (from Rs 3,040.60 crore in Q4FY25). Total income for FY26 was Rs 14,460.24 crore, registering a 12.24% YoY growth against Rs 12,883.46 crore in FY25. Profit After Tax (PAT): Surged to Rs 370.80 crore in Q4FY26, marking a robust growth of 74.38% QoQ (from Rs 212.64 crore in Q3FY26) and 107.26% YoY (from Rs 178.91 crore in Q4FY25). For FY26, PAT stood at Rs 855.98 crore, up by 41.66% YoY compared to Rs 604.27 crore in FY25. EBITDA (Profit before interest, depreciation, tax and exceptional item): Recorded at Rs 399.64 crore in Q4FY26, down by 28.68% QoQ (from Rs 560.37 crore in Q3FY26) and 6.30% YoY (from Rs 426.51 crore in Q4FY25). For FY26, EBITDA stood at Rs 1,693.67 crore, growing by 15.03% YoY from Rs 1,472.40 crore in FY25. Standalone Financial Highlights: Revenue from Operations: Stood at Rs 3,211.70 crore in Q4FY26, declining by 16.75% QoQ (from Rs 3,858.02 crore in Q3FY26) and growing by 8.69% YoY (from Rs 2,955.01 crore in Q4FY25). For FY26 revenue was Rs 13,796.72 crore, an increase of 10.89% YoY from Rs 12,441.96 crore in FY25. Total Income: Recorded at Rs 3,259.38 crore in Q4FY26, down by 16.17% QoQ (from Rs 3,888.25 crore in Q3FY26) and up by 9.53% YoY (from Rs 2,975.85 crore in Q4FY25). FY26 total income reached Rs 13,995.33 crore, growing 11.21% YoY from Rs 12,584.31 crore in FY25. Profit After Tax (PAT): Reported at Rs 370.99 crore in Q4FY26, displaying an impressive jump of 84.24% QoQ (from Rs 201.36 crore in Q3FY26) and 112.37% YoY (from Rs 174.69 crore in Q4FY25). For FY26, net profit was Rs 837.55 crore, up by 47.84% YoY from Rs 566.53 crore in FY25. Business Highlights: Dividend: The Board recommended a Final Dividend of 200% (Rs 4.00 per equity share of face value Rs 2 each) for FY26. If approved, the total dividend for FY26 would aggregate to 560% (Rs 11.20 per equity share), which includes the 1st and 2nd interim dividends of Rs 3.60 each declared earlier in the financial year. Capacity Commissioning: The Company commissioned its balance capacity of 17,000 TPA of Epichlorohydrin (ECH) at the chemical complex in Jhagadia, Bharuch District, Gujarat, on April 01, 2026. With this, the ECH plant having a total capacity of 52,000 TPA has been fully commissioned. Strategic Investments: The Board approved a capital expenditure plan for its wholly owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), to undertake a capital investment of Rs 101 crore towards augmenting its Formulated Resins (FR) capacity by 36K TPA (making the total FR capacity 50,000 TPA). The Board also approved financial assistance to HSCL of up to Rs 100 crore through a mix of Equity and Debt. Joint Venture Restructuring: The Company, along with its wholly owned subsidiary Shriram Polytech Limited, executed a Joint Venture Agreement with Teknor Apex B.V. and sold a 50% equity stake in Shriram Polytech Limited. Consequently, Shriram Polytech Limited ceased to be a subsidiary and became a Joint Venture w.e.f. April 17, 2026. Cancellation of Forfeited Shares: The Board approved the cancellation of 39,00,000 forfeited equity shares of Rs 2 each (amounting to a paid-up value of Rs 15.60 lakh), subject to shareholder approval. Regulatory Updates: Following a detailed review of the implications of the New Labour Codes, the Company reversed a provision of Rs 31.62 crore during Q4FY26, which was presented under exceptional items. Segment-wise Performance: Chemicals and Vinyl: Generated revenue of Rs 1,306.97 crore in Q4FY26 and Rs 4,650.99 crore for FY26. Sugar and Ethanol: Contributed Rs 1,171.05 crore in Q4FY26 and Rs 4,496.17 crore for FY26. Fenesta Building Systems: Recorded revenue of Rs 293.58 crore in Q4FY26 and Rs 1,112.20 crore in FY26. Shriram Farm Solutions: Achieved Rs 112.59 crore in Q4FY26 and Rs 1,689.08 crore in FY26. Fertiliser: Stood at Rs 322.95 crore in Q4FY26 and Rs 1,444.80 crore for the full year FY26. Bioseed: Contributed Rs 101.55 crore in Q4FY26 and Rs 665.80 crore for the full year FY26. Others: Recorded revenue of Rs 82.17 crore in Q4FY26 and Rs 286.41 crore in FY26. Result PDF
- Trendlyne
- 2 weeks 3 days ago
Diversified company DCM Shriram announced Q3FY26 results Revenue: Rs 4,003.3 lakh against Rs 3,518.9 lakh during Q3FY25, change 14%. PBT: Rs 377.5 lakh against Rs 385.5 lakh during Q3FY25, change -2%. PAT: Rs 212.6 lakh against Rs 262.1 lakh during Q3FY25, change -19%. EPS: Rs 15.9 for Q3FY26. Ajay Shriram, Chairman & Senior Managing Director & Vikram Shriram, Vice Chairman & Managing Director, said: "The global business environment is being reshaped by heightened geopolitical volatility, tighter financial conditions and rapid technological disruption. Trade realignments, selective tariff actions and prolonged regional conflicts are disrupting supply chains, elevating cost structures and constraining long-term capital planning. Amid this uncertainty, India stands out with quiet confidence—supported by resilient macroeconomic fundamentals and a demographic dividend that is increasingly translating into consumption, entrepreneurship and formalization of the economy. Against this backdrop, our Chemicals business delivered volume-led growth during the quarter. Our strategic pivot toward downstream adjacencies continues to gain momentum, with the Epichlorohydrin (ECH) facility commissioned in the previous quarter witnessing encouraging market acceptance. The announcement of anti-dumping duty on liquid epoxy resins is expected to accelerate the turnaround of our acquisition done last quarter. We remain focused on ramping up capacity utilization across both ECH and Epoxy, which will also enhance the integrated utilization of caustic soda and chlorine. In the Sugar and Ethanol business, domestic production estimates have been revised downwards, and the Government has announced an export quota of 1.5 MMT. Despite these developments, an estimated closing stock of approximately 6.2 MMT is expected for the season. Concurrently, an increase in the State Advised Price (SAP) has elevated cost pressures, leading the industry to engage with the Government for support through higher sugar MSP and increased ethanol blending targets to ensure the long-term viability of mills. Fenesta Building Systems continues to strengthen its position in the building materials space by expanding and diversifying its product and service offerings, enhancing service quality, and increasing its share of customers’ overall wallet through deeper engagement. Shriram Farm Solutions delivered resilient growth during the quarter, driven by strong performance in the crop protection segment and research wheat seed, where we further strengthened our leadership position with the highest-ever quarterly sales. Supported by a strong balance sheet and disciplined capital allocation, we remain well positioned to pursue growth opportunities in businesses aligned with our long-term strategic priorities, as we continue to build resilient & future-ready businesses." Result PDF
- Trendlyne
- 4 months 1 week ago
DCM Shriram Financials
DCM Shriram Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,127.72
- 50 Day
- ₹1,140.00
- 100 Day
- ₹1,147.81
- 200 Day
- ₹1,158.35
Resistance and Support
- R3 1,150.83
- R2 1,122.17
- R1 1,079.43
- S1 1,008.03
- S2 979.37
- S3 936.63
DCM Shriram Corporate Actions - Bonus, Splits, Dividends
About DCM Shriram
- NSE Symbol
- DCMSHRIRAM
- BSE Symbol
- 523367
- Joint Managing Director
- Mr. Ajit S Shriram
- ISIN
- INE499A01024
Similar Stocks to DCM Shriram
Popular Stocks
DCM Shriram FAQs
DCM Shriram share price is ₹1,036 As on 31 May, 2026 | 16:24
The Market Cap of DCM Shriram is ₹16166.5 Cr As on 31 May, 2026 | 16:24
The P/E ratio of DCM Shriram is 18.9 As on 31 May, 2026 | 16:24
The PB ratio of DCM Shriram is 2.2 As on 31 May, 2026 | 16:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.